We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The analytics firm Clarivate has named 15 drugs that are either likely to achieve blockbuster status or to be game-changers benefiting millions of patients in its report Drugs to Watch 2023. Read More
Undisclosed tadalafil and sildenafil in a “male enhancement” supplement and lorcaserin — a controlled substance that has been withdrawn from the U.S. market — hidden in a weight-loss supplement, have earned Adam’s Secret USA an FDA warning letter. Read More
The FDA encourages developers of drugs and biological treatments for monkey pox — or mpox — to request a preapplication meeting with the agency, according to a draft guidance released today. Read More
Brand-name drugmakers will have to pay the UK government nearly $4.1 billion this year, a sharp increase from approximately $2.2 billion in 2022. Read More
In the ongoing battle of pro-life groups vs. the government on access to the so-called abortion pill, the FDA is pressing a Texas judge to reject a request by anti-abortion groups for a court order withdrawing federal approval for the drug. Read More
AbbVie and Eli Lilly have pulled out of a voluntary UK drug pricing agreement for the National Health Service (NHS) — a move that could leave NHS patients with curtailed access to their therapies. Read More
Oncology drug trials should consider a wide range of dosages and how they impact a wide variety of participants, rather than immediately titrating patients up to the maximum tolerated dose (MTD), the FDA said in a new draft guidance. Read More
Reforms in orphan drug exclusivity will see significant movement in 2023, according to Andi Fristedt, the FDA’s deputy commissioner for policy, legislation, and international affairs. Read More
The European Medicines Agency (EMA)’s safety committee has recommended measures to reduce the serious side effects linked with Janus kinase (JAK) inhibitors used to treat chronic inflammatory disorders. Read More